Autonomix Medical (AMIX) News Today $1.11 -0.15 (-11.90%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$1.07 -0.04 (-3.60%) As of 10/10/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AMIX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Autonomix granted U.S patent on platform enabling precision therapiesOctober 9 at 12:43 PM | msn.comAutonomix Medical stock rises after securing new cardiac treatment patentOctober 9 at 12:43 PM | za.investing.comAutonomix Medical, Inc. Strengthens IP Portfolio with New Patent for Precision Nerve-Targeted Cardiac TreatmentsOctober 9 at 9:10 AM | quiverquant.comQAutonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in CardiologyOctober 9 at 8:45 AM | globenewswire.comAutonomix Medical, Inc. Announces Release of the Next CEO Corner SegmentOctober 2, 2025 | globenewswire.comAutonomix Medical Initiates Key GLP Preclinical Study to Advance Regulatory Pathway for Sensing and RF Ablation SystemSeptember 29, 2025 | quiverquant.comQAutonomix Medical, Inc. Initiates Good Laboratory Practice (GLP) Study for Sensing and RF Ablation SystemSeptember 29, 2025 | globenewswire.comAutonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2025 CIRSE Annual CongressSeptember 9, 2025 | finance.yahoo.comAutonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” SegmentSeptember 4, 2025 | globenewswire.comAutonomix announces longer-term post hoc data from PoC 1 trialSeptember 3, 2025 | msn.comAutonomix Medical, Inc. Demonstrates Sustained Pain Reduction, Quality of Life Gains and 100% Zero Opioid Use in Longer-Term Post Hoc Analysis from PoC 1 StudySeptember 3, 2025 | globenewswire.comAutonomix Medical, Inc. to Present at H.C. Wainwright 27th Annual Global Investment ConferenceSeptember 2, 2025 | quiverquant.comQAutonomix Medical, Inc. to Present at H.C. Wainwright 27th Annual Global Investment ConferenceSeptember 2, 2025 | globenewswire.comAutonomix Medical Raises Stock Sales PriceAugust 27, 2025 | tipranks.comAutonomix Medical Enters $15M Purchase AgreementAugust 27, 2025 | msn.comAutonomix Medical Inc News (AMIX) - Investing.comAugust 24, 2025 | investing.comAutonomix Medical, Inc. Granted New European Patent for First-in-Class Catheter-Based TechnologyAugust 20, 2025 | finance.yahoo.comAutonomix Medical, Inc. Expands Patent Portfolio with New European Patent to Enhance Medical Device Technology for Physiological MonitoringAugust 20, 2025 | quiverquant.comQAutonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann ...August 18, 2025 | gurufocus.comAutonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann ...August 18, 2025 | gurufocus.comAutonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc.August 18, 2025 | globenewswire.comAutonomix Medical, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTechAugust 15, 2025 | globenewswire.comAutonomix Medical, Inc. Finalizes Design Review of First-Ever Intravascular Nerve Sensing ...August 14, 2025 | gurufocus.comAutonomix Medical, Inc. Finalizes Design Review of First-Ever Intravascular Nerve Sensing ...August 14, 2025 | gurufocus.comAutonomix Medical, Inc. Finalizes Design Review of First-Ever Intravascular Nerve Sensing Catheter in Key Step Toward U.S. Clinical StudiesAugust 14, 2025 | globenewswire.comAutonomix Medical Inc. (AMIX) Stock Price Today - WSJJuly 24, 2025 | wsj.comAutonomix Medical, Inc. Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand ConferenceJuly 22, 2025 | uk.finance.yahoo.comAutonomix Medical, Inc. Exercise of Warrants for $2.5 Million Gross ProceedsJuly 22, 2025 | finance.yahoo.comAutonomix Medical, Inc. Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand ConferenceJuly 22, 2025 | globenewswire.comAutonomix Medical Shares Jump 13% Following Smart Torquer Patent ApprovalJuly 21, 2025 | msn.comAutonomix Medical stock gains after securing smart torquer patentJuly 21, 2025 | investing.comAutonomix Medical, Inc. Granted New U.S. Patent to Advance Minimally Invasive, Nerve-Focused Treatments Across High-Need IndicationsJuly 21, 2025 | globenewswire.comAutonomix releases next CEO Corner segmentJuly 7, 2025 | msn.comAutonomix Medical, Inc. Announces Release of the Next CEO Corner SegmentJuly 7, 2025 | globenewswire.comAutonomix Medical, Inc. (AMIX) Gets a Buy from Maxim GroupJuly 4, 2025 | theglobeandmail.comAutonomix Medical, Inc. Treats First Patient in Follow-On Market Expansion Phase (PoC 2) of Proof-of-Concept Human Clinical Study - FinanzNachrichten.deJuly 2, 2025 | finanznachrichten.deAutonomix Medical, Inc. Treats First Patient in Follow-On Market Expansion Phase (“PoC 2”) of Proof-of-Concept Human Clinical StudyJune 30, 2025 | globenewswire.comAutonomix Medical, Inc. Expands Global Intellectual Property Portfolio with Issuance of U.S. Patent for Innovative Nerve-Targeted Treatment Technologies - NasdaqJune 29, 2025 | nasdaq.comAutonomix Medical, Inc. Granted New U.S. Patent for Innovative Catheter-Based Platform TechnologyJune 27, 2025 | gurufocus.comAutonomix Medical, Inc. Granted New U.S. Patent for Innovative Catheter-Based Platform ...June 27, 2025 | gurufocus.comAutonomix Medical, Inc. Granted New U.S. Patent for Innovative Catheter-Based Platform TechnologyJune 27, 2025 | globenewswire.comAutonomix Medical, Inc. Granted Approval to Expand Proof-of-Concept Human Clinical Study, Doubling Potential Addressable Market Beyond Pancreatic Cancer PainJune 5, 2025 | globenewswire.comAutonomix Medical, Inc. Announces Follow-On Phase of Clinical Trial to Expand Treatment Options for Cancer Pain ManagementMay 15, 2025 | nasdaq.comAutonomix Medical, Inc. Granted Key U.S. Patent for Innovative Catheter-Based Platform TechnologyMay 15, 2025 | globenewswire.comAutonomix CEO Brad Hauser to Present at Virtual Investor's Closing Bell EventMay 14, 2025 | globenewswire.comBrad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable MarketMay 13, 2025 | finance.yahoo.comBrad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable MarketMay 13, 2025 | globenewswire.comAutonomix Highlights Compelling Patient Testimonial Showing Rapid Pain Relief from First-in-Human Proof-of-Concept Trial in Pancreatic Cancer PainMay 5, 2025 | globenewswire.comAutonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Highlighting Key Learnings from First-In-Human Trial and Extension into Visceral Cancer PainMay 1, 2025 | globenewswire.comAutonomix Medical, Inc. Reports Positive Outcomes in Initial Phase of First-in-Human ...April 30, 2025 | gurufocus.com Get Autonomix Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AMIX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AMIX Media Mentions By Week AMIX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMIX News Sentiment▼0.840.77▲Average Medical News Sentiment AMIX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMIX Articles This Week▼62▲AMIX Articles Average Week Get the Latest News and Ratings for AMIX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Autonomix Medical and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Retractable Technologies News Today Vivos Therapeutics News Today NexGel News Today IRIDEX News Today enVVeno Medical News Today Envoy Medical News Today Nexalin Technology News Today Helius Medical Technologies News Today Inspira Technologies OXY B.H.N. News Today SeaStar Medical News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMIX) was last updated on 10/11/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Autonomix Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Autonomix Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
